Cargando…
Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
BACKGROUND: We measured antibody-dependent cell mediated cytotoxicity (ADCC) activity in serum and genital fluids of heterosexually exposed women during HIV seroconversion. METHODS: Plasma and cervico-vaginal lavage (CVL) fluid from 11 seroconverters (SC) were analyzed biannually from one year pre-...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718584/ https://www.ncbi.nlm.nih.gov/pubmed/26798561 http://dx.doi.org/10.4172/2155-6113.1000479 |
_version_ | 1782410819796992000 |
---|---|
author | Aziz, Mariam Mahmood, Fareeha Mata, Mariana Durkin, Helen G Liu, Chenglong Greenblatt, Ruth M Nowicki, Marek Golub, Elizabeth T Anastos, Kathryn French, Audrey L Baum, Linda L |
author_facet | Aziz, Mariam Mahmood, Fareeha Mata, Mariana Durkin, Helen G Liu, Chenglong Greenblatt, Ruth M Nowicki, Marek Golub, Elizabeth T Anastos, Kathryn French, Audrey L Baum, Linda L |
author_sort | Aziz, Mariam |
collection | PubMed |
description | BACKGROUND: We measured antibody-dependent cell mediated cytotoxicity (ADCC) activity in serum and genital fluids of heterosexually exposed women during HIV seroconversion. METHODS: Plasma and cervico-vaginal lavage (CVL) fluid from 11 seroconverters (SC) were analyzed biannually from one year pre- to 6 year post-seroconversion using a (51)Cr-release assay to measure HIV-1 gp120 specific ADCC. RESULTS: No SC had significant HIV specific CVL ADCC activity before seroconversion or until 1.5 yr after seroconversion. One individual had a %Specific Release (SR) of 25.4 at 2 years, 26.7 at 3 years and 21.0 at 4 years after seroconversion in CVL. Another sample had 4.7% SR at 2 years, 5.3 at 3 years, 10.9 at 4 years, and 8.4 at 5 years after seroconversion in CVL. A third had no activity until 17% SR 5 years after seroconversion in CVL. A fourth showed activity of 36.5% SR at 6.5 years after seroconversion. Seven women had no ADCC activity in their CVL. Paired serum samples showed HIV specific ADCC activity prior to the appearance of CVL ADCC activity. CONCLUSIONS: HIV specific ADCC activity in CVL rose 2 years after seroconversion; ADCC was present in the serum prior to this time. These data suggest that genital tract ADCC activity is not present until well after acute infection. |
format | Online Article Text |
id | pubmed-4718584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
record_format | MEDLINE/PubMed |
spelling | pubmed-47185842016-01-19 Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters Aziz, Mariam Mahmood, Fareeha Mata, Mariana Durkin, Helen G Liu, Chenglong Greenblatt, Ruth M Nowicki, Marek Golub, Elizabeth T Anastos, Kathryn French, Audrey L Baum, Linda L J AIDS Clin Res Article BACKGROUND: We measured antibody-dependent cell mediated cytotoxicity (ADCC) activity in serum and genital fluids of heterosexually exposed women during HIV seroconversion. METHODS: Plasma and cervico-vaginal lavage (CVL) fluid from 11 seroconverters (SC) were analyzed biannually from one year pre- to 6 year post-seroconversion using a (51)Cr-release assay to measure HIV-1 gp120 specific ADCC. RESULTS: No SC had significant HIV specific CVL ADCC activity before seroconversion or until 1.5 yr after seroconversion. One individual had a %Specific Release (SR) of 25.4 at 2 years, 26.7 at 3 years and 21.0 at 4 years after seroconversion in CVL. Another sample had 4.7% SR at 2 years, 5.3 at 3 years, 10.9 at 4 years, and 8.4 at 5 years after seroconversion in CVL. A third had no activity until 17% SR 5 years after seroconversion in CVL. A fourth showed activity of 36.5% SR at 6.5 years after seroconversion. Seven women had no ADCC activity in their CVL. Paired serum samples showed HIV specific ADCC activity prior to the appearance of CVL ADCC activity. CONCLUSIONS: HIV specific ADCC activity in CVL rose 2 years after seroconversion; ADCC was present in the serum prior to this time. These data suggest that genital tract ADCC activity is not present until well after acute infection. 2015-07-09 2015-07 /pmc/articles/PMC4718584/ /pubmed/26798561 http://dx.doi.org/10.4172/2155-6113.1000479 Text en http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Article Aziz, Mariam Mahmood, Fareeha Mata, Mariana Durkin, Helen G Liu, Chenglong Greenblatt, Ruth M Nowicki, Marek Golub, Elizabeth T Anastos, Kathryn French, Audrey L Baum, Linda L Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters |
title | Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters |
title_full | Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters |
title_fullStr | Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters |
title_full_unstemmed | Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters |
title_short | Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters |
title_sort | development of igg mediated antibody dependent cell-mediated cytotoxicity (adcc) in the serum and genital mucosa of hiv seroconverters |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718584/ https://www.ncbi.nlm.nih.gov/pubmed/26798561 http://dx.doi.org/10.4172/2155-6113.1000479 |
work_keys_str_mv | AT azizmariam developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters AT mahmoodfareeha developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters AT matamariana developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters AT durkinheleng developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters AT liuchenglong developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters AT greenblattruthm developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters AT nowickimarek developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters AT golubelizabetht developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters AT anastoskathryn developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters AT frenchaudreyl developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters AT baumlindal developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters |